January 2024
1. SALJE H
   Achieving zero deaths from dengue virus under evolving population immunity.
   Lancet Infect Dis. 2024;24:12-13.
   

   >> Share

   
   June 2023
2. LOW JG, Ooi EE
   Inactivated Zika virus vaccine and the complexity of flavivirus antigenicity.
   Lancet Infect Dis. 2023 Jun 27:S1473-3099(23)00202.
   

   >> Share

   
   
3. KOREN MA, Lin L, Eckels KH, De La Barrera R, et al
   Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.
   Lancet Infect Dis. 2023 Jun 27:S1473-3099(23)00192.
   

   >> Share

   
   January 2023
4. WILDER-SMITH A, Durbin A
   Promising efforts to develop an mRNA vaccine against Zika.
   Lancet Infect Dis. 2023 Jan 19:S1473-3099(22)00827.
   

   >> Share

   
   
5. ESSINK B, Chu L, Seger W, Barranco E, et al
   The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials.
   Lancet Infect Dis. 2023 Jan 19:S1473-3099(22)00764.
   

   >> Share

   
   May 2021
6. CASTANHA PMS, Marques ETA
   Zika vaccines: can we solve one problem without creating another one?
   Lancet Infect Dis. 2021 May 18. pii: S1473-3099(20)30768.
   

   >> Share

   
   
7. HAN HH, Diaz C, Acosta CJ, Liu M, et al
   Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial.
   Lancet Infect Dis. 2021 May 18. pii: S1473-3099(20)30733.
   

   >> Share

   
   
8. SIE A, Hanefeld J, Chaponda M, Chico RM, et al
   Congenital malformations in sub-Saharan Africa-warnings of a silent epidemic?
   Lancet Infect Dis. 2021;21:594-596.
   

   >> Share

   
   December 2020
9. MAHE D, Bourgeau S, Frouard J, Joguet G, et al
   Long-term Zika virus infection of non-sperm cells in semen.
   Lancet Infect Dis. 2020;20:1371.
   

   >> Share

   
   October 2020
10. ADES AE, Soriano-Arandes A, Alarcon A, Bonfante F, et al
    Vertical transmission of Zika virus and its outcomes: a Bayesian synthesis of prospective studies.
    Lancet Infect Dis. 2020 Oct 14. pii: S1473-3099(20)30432.
    

    >> Share

    
    
11. EINSPIELER C, Marschik PB
    Desideratum: a developmentalist view of Zika virus infection.
    Lancet Infect Dis. 2020 Oct 14. pii: S1473-3099(20)30454.
    

    >> Share

    
    July 2020
12. WILLIAMSON PC, Biggerstaff BJ, Simmons G, Stone M, et al
    Evolving viral and serological stages of Zika virus RNA-positive blood donors and estimation of incidence of infection during the 2016 Puerto Rican Zika epidemic: an observational cohort study.
    Lancet Infect Dis. 2020 Jul 13. pii: S1473-3099(19)30706.
    

    >> Share

    
    
13. STONE M, Bakkour S, Lanteri MC, Brambilla D, et al
    Zika virus RNA and IgM persistence in blood compartments and body fluids: a prospective observational study.
    Lancet Infect Dis. 2020 Jul 13. pii: S1473-3099(19)30708.
    

    >> Share

    
    
14. PETERSEN LR, Cassetti MC
    Learning about Zika virus epidemiology and diagnostics from blood donor studies.
    Lancet Infect Dis. 2020 Jul 13. pii: S1473-3099(20)30125.
    

    >> Share

    
    May 2020
15. STEPHENSON KE, Tan CS, Walsh SR, Hale A, et al
    Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.
    Lancet Infect Dis. 2020 May 6. pii: S1473-3099(20)30085.
    

    >> Share

    
    
16. CASTANHA PMS, Marques ETA
    Vaccine development during global epidemics: the Zika experience.
    Lancet Infect Dis. 2020 May 6. pii: S1473-3099(20)30360.
    

    >> Share

    
    February 2020
17. ADES AE, Thorne C, Soriano-Arandes A, Peckham CS, et al
    Researching Zika in pregnancy: lessons for global preparedness.
    Lancet Infect Dis. 2020 Feb 18. pii: S1473-3099(20)30021.
    

    >> Share

    
    
18. WIJESOORIYA SL, Nguyen CT, Nguyen TTT, Vu TBH, et al
    Long-term surveillance needed to detect Zika virus outbreaks in endemic regions.
    Lancet Infect Dis. 2020;20:168-169.
    

    >> Share

    
    January 2020
19. BUJAN L, Mansuy JM, Hamdi S, Pasquier C, et al
    1 year after acute Zika virus infection in men.
    Lancet Infect Dis. 2020;20:25-26.
    

    >> Share

    
    
20. BECKER-DREPS S, Stringer EM, Bucardo F, Bowman NM, et al
    Is there a silver lining to the Zika virus epidemic in the Americas?
    Lancet Infect Dis. 2020;20:14-15.
    

    >> Share

    
    December 2019
21. BURGER-CALDERON R, Bustos Carrillo F, Gresh L, Ojeda S, et al
    Age-dependent manifestations and case definitions of paediatric Zika: a prospective cohort study.
    Lancet Infect Dis. 2019 Dec 20. pii: S1473-3099(19)30547.
    

    >> Share

    
    
22. PAZ-BAILEY G, Gregory CJ
    Balancing sensitivity and specificity of Zika virus case definitions.
    Lancet Infect Dis. 2019 Dec 20. pii: S1473-3099(19)30686.
    

    >> Share

    
    October 2019
23. HILL SC, Vasconcelos J, Neto Z, Jandondo D, et al
    Emergence of the Asian lineage of Zika virus in Angola: an outbreak investigation.
    Lancet Infect Dis. 2019;19:1138-1147.
    

    >> Share

    
    
24. GILBOA SM, Gregory CJ, Honein MA
    Better surveillance to protect mothers and infants from Zika.
    Lancet Infect Dis. 2019;19:1047-1048.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share